Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA1143 pseudogene 1 (abbreviated as KIAA1143P1) is a pseudogene in humans, annotated as such by major genomic databases[4][6]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to accumulation of mutations that prevent their transcription or translation[2]. KIAA1143P1 is not known to produce a functional protein and has no demonstrated biological function, disease association, or therapeutic targeting relevance. It is distinct from the related protein-coding gene KIAA1143, which encodes an uncharacterized protein potentially involved in cell division and cytoskeletal regulation[1][3]. There are no known drugs, mechanisms of action, or biomarker applications related to KIAA1143P1. The entry may be considered incorrect or irrelevant for therapeutic target research because pseudogenes are generally not therapeutic targets and lack biological activity[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KIAA1143 pseudogene 1 (KIAA1143P1).